Clover Health (NASDAQ:CLOV) stock tumbles 20% despite solid Q2 2025 earnings as investors focused on its projected medical ...

A free account provides you access to a limited number of free articles each month, plus newsletters, job postings, salary ...

Montana's plan largely aligns with the federal law, but it would create additional exemptions, including for people who are ...

Clinical data and cost-effectiveness analysis demonstrates the VenoValve would provide both better health outcomes and lower costs compared to current standard of care treatments ...